Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma Meeting Abstract


Authors: Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; Straus, D. J.; Kumar, A.; Moskowitz, C. H.; Dicostanzo, J.; Callan, D.; Tsui, D.; Rademaker, J.; Schoder, H.; Ni, A.; Younes, A.
Abstract Title: Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 404s
Language: English
ACCESSION: WOS:000442916002590
DOI: 10.1200/JCO.2018.36.15_suppl.7520
PROVIDER: wos
Notes: Meeting Abstract: 7520 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Craig Moskowitz
    388 Moskowitz
  2. Heiko Schoder
    330 Schoder
  3. Andrew D Zelenetz
    599 Zelenetz
  4. Alison Moskowitz
    179 Moskowitz
  5. Paul Hamlin
    186 Hamlin
  6. Matthew J Matasar
    149 Matasar
  7. David J Straus
    245 Straus
  8. Anita Kumar
    67 Kumar
  9. Connie Wing-Ching Lee
    69 Lee
  10. Anas Younes
    246 Younes
  11. Devin Eileen Callan
    3 Callan
  12. Ai   Ni
    82 Ni
  13. Wai Yi   Tsui
    27 Tsui
Related MSK Work